News
Company news and developments, with original sources and dates.
Updated from source
Funding RSS ↗Anda Biotechnology completes Series A+ financing
On 2026-08-01, according to Xiniu Data, Anda Biotechnology completed Series A+ financing for an undisclosed amount. Investors were lead investor Anhui Hongtaihekang Phase One Venture Capital Fund Partnership (Limited Partnership), participating investor Beijing Changping Industry Development Investment Fund (Limited Partnership), participating investor Feixizipeng Venture Capital Partnership (Limited Partnership), participating investor Hefei Guoshengweilaikezhuan Venture Capital Fund Partnership (Limited Partnership). The company is a developer of personalized oncology neoantigen vaccines.
Anda Biotechnology completes equity financing for an undisclosed amount
On 2026-04-10, according to Xiniu Data, Anda Biotechnology completed equity financing for an undisclosed amount. The investor was Gongqingcheng Kunyuan Investment Partnership (Limited Partnership). The company develops personalized tumor neoantigen vaccines.
Anda Biotechnology completes strategic financing
Brief not available.
Anda Biotechnology raises tens of millions of RMB in Series A financing
Brief not available.